Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05718726Recruiting
Infection risk after spleen removal surgery
This study looks at how often infections happen after spleen removal during surgery for cancer in the belly. It aims to help doctors better protect patients from serious infections.
Basingstoke, HampshireAges 18–79 - NCT07861282Recruiting
Home exercise program for recovery after lung cancer surgery
This study tests a home-based exercise program delivered through a smartphone or computer to help you recover after lung cancer surgery. It may improve your strength, stamina, and overall recovery.
Seville, AndalusiaAges 18–80 - NCT07052630Recruiting
Planning advance care after stem cell transplant
This study tests a program that helps stem cell transplant survivors plan their future care with their doctors. It uses a website and a patient navigator to guide you through conversations about your goals and values.
Seattle, WashingtonAges 18 years+ - NCT05476939RecruitingPhase 3
BIOMEDE 2.0 trial for DIPG and similar brainstem gliomas
This phase 3 study tests targeted treatments (ONC201 or everolimus) for children with DIPG or similar diffuse midline brain tumors, based on the tumor’s genetic markers. It aims to improve outcomes by matching treatment to the tumor biology and comparing approaches in a randomized way.
BrusselsAges 6 months+ - NCT06898996Recruiting
Stool test study for Lynch syndrome colon screening
This trial tests a new stool-based test (FIT) to see if it can help find colon cancer early in people with Lynch syndrome. You will collect stool samples at home and complete surveys before your regular colonoscopy.
Chicago, IllinoisAges 20–80 - NCT06764316RecruitingPhase 1
Safety study of BAY 3547926 for advanced liver cancer
This trial tests a new drug called BAY 3547926 for people with advanced liver cancer that cannot be removed with surgery or has not responded to other treatments. The goal is to see if the drug is safe and how well it works.
Dothan, AlabamaAges 18 years+ - NCT06004245RecruitingPhase 1
Study of new drug for advanced solid tumors with certain genetic markers
This trial is testing a new oral medication, VVD-133214, for people with advanced solid tumors that have a specific genetic feature called MSI-high or dMMR. The study will see if the drug is safe and effective when given alone or with other drugs like bevacizumab or pembrolizumab.
Tucson, ArizonaAges 18 years+ - NCT07535008Recruiting
Dental Cleaning to Prevent Graft-Versus-Host Disease
This study tests whether professional dental cleaning after a stem cell transplant can help prevent chronic graft-versus-host disease (GVHD), a condition where transplanted immune cells attack your body. You'll receive dental cleanings and be followed for one year to see if this simple preventive step reduces GVHD complications.
Seattle, WashingtonAges 18 years+ - NCT07437950RecruitingPhase 2
Comparing treatment lengths for venetoclax in older adults with newly diagnosed acute myeloid leukemia
This study tests whether a shorter or longer course of the drug venetoclax works better for older adults with a type of blood cancer called acute myeloid leukemia (AML) who are not healthy enough for intensive chemotherapy. The goal is to find the best treatment duration to control the cancer while reducing side effects.
Coeur d'Alene, IdahoAges 60 years+ - NCT06669104Recruiting
Chest surgery using the Medtronic Hugo robot
This study tests whether a robotic system (Medtronic Hugo) can safely help surgeons perform chest surgery with small cuts. If you need chest surgery and are in good health, you may be able to join.
Hong KongAges 18–80 - NCT05828069RecruitingPhase 2
Tovorafenib for young people with worsening Langerhans cell histiocytosis
This Phase 2 trial tests tovorafenib (DAY101) to treat children and young people whose Langerhans cell histiocytosis (LCH) is getting worse, came back, or did not respond to prior treatment. It may help by targeting certain gene changes found in the LCH.
Birmingham, AlabamaAges 6 months–22 years - NCT07735611Recruiting
Comparing robotic bronchoscopy systems for examining lung spots
This study compares two robotic bronchoscopy systems used to examine lung spots or nodules. Participation involves having your scheduled procedure, and researchers will evaluate which system works better.
Cleveland, OhioAges 18 years+ - NCT07493304RecruitingPhase 3
Preventing blood clots in people with cancer
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
Hialeah, FloridaAges 18 years+ - NCT06172296RecruitingPhase 3
Dinutuximab plus transplant for high-risk neuroblastoma
This trial tests adding a targeted drug called dinutuximab to standard chemotherapy, surgery, and a stem cell transplant for children and young adults with a new diagnosis of high-risk neuroblastoma. The goal is to see if this combination helps more patients stay in remission.
Birmingham, AlabamaAges Up to 30 years - NCT07356154RecruitingPhase 1/Phase 2
Combination treatment for leukemia that has returned or not responded
This study tests two experimental drugs, revumenib and mezigdomide, for people with acute leukemia that has not responded to treatment or has come back. The goal is to see if this combination can help control the disease and improve outcomes.
Duarte, CaliforniaAges 12 years+ - NCT06581432RecruitingPhase 2
Zongertinib for advanced cancers with HER2 changes
This trial tests a new pill called zongertinib for people with advanced cancers that have HER2 changes. It may help when other treatments have stopped working, and it targets the HER2 protein to slow or stop tumor growth.
Anchorage, AlaskaAges 18 years+ - NCT07884474Recruiting
Remote saliva collection for childhood leukemia survivors
This study tests whether it is easy and acceptable for childhood leukemia survivors, their siblings, and caregivers to collect saliva samples at home and send them to researchers. It aims to understand how well this remote method works for future research.
Memphis, TennesseeAges 8–18 - NCT07882888RecruitingPhase 2
Immunotherapy drugs with cetuximab for treatable mouth cancer
This trial tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus cetuximab for people with oral cancer that can be removed by surgery. The goal is to see if this treatment shrinks tumors and helps patients before their operation.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06421155Recruiting
MRI scans of the brain for children and young adults with leukemia
This study uses a special type of magnetic resonance imaging (MRI) to look at the brain of people with acute leukemia. It aims to see if this MRI technique can help doctors better understand the effects of leukemia and its treatment on the brain.
Cleveland, OhioAges Up to 30 years - NCT06395441RecruitingPhase 3
Wisconsin ginseng for cancer-related fatigue
This study tests whether a daily dose of Wisconsin ginseng can help reduce tiredness and improve energy in people who have had or are currently receiving treatment for cancer. It aims to find out if this natural supplement can safely improve fatigue without interfering with their cancer care.
Albert Lea, MinnesotaAges 18 years+ - NCT07819760Recruiting
Prostate removal without prior biopsy for suspected cancer
This study looks at whether removing the prostate gland without doing a biopsy first is safe and effective for men with a high PSA and strong signs of cancer on imaging. If you qualify, you would have surgery to remove your prostate, and the tissue would be checked during the operation to guide further treatment.
Moscow, MoscowAges 18 years+ - NCT06101069Recruiting
New MRI technique to identify brain changes after radiation
This study tests a new MRI technique to better tell apart tumor regrowth from tissue changes caused by previous radiation therapy. If you've had brain radiation or have a new brain tumor, this imaging could help guide your next steps.
Cleveland, OhioAges 18–60 - NCT07455955RecruitingPhase 2
Personalized nausea control for early breast cancer chemo
This trial offers a personalized anti-nausea (antiemetic) plan based on your genetic profile. It's for Chinese women starting their first chemo for early breast cancer, aiming to find the best way to prevent nausea and vomiting during treatment.
Hong KongAges 18–74 - NCT07099898RecruitingPhase 3
Study of a new drug for relapsed small cell lung cancer
This study tests a new drug (GSK5764227) for people whose extensive-stage small cell lung cancer has gotten worse after platinum chemotherapy combined with immunotherapy. The goal is to see if this targeted treatment can help shrink tumors and control the cancer.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.